
Best mid-cap healthcare stocks to invest in 2025
The healthcare sector continues to present robust investment opportunities, particularly in the mid-cap space, where innovation meets scalability. These companies are at the forefront of providing cutting-edge medical solutions, expanding access to care, and driving significant growth in niche markets. Telix Pharmaceuticals leads the way in radiopharmaceutical development, specializing in targeted radiation therapies for cancer diagnosis and treatment. Its innovative approach to precision medicine positions it strongly in the growing theranostics market. Krystal Biotech focuses on gene therapy treatments for rare skin diseases, leveraging its proprietary HSV-1-based delivery platform to create transformative treatments. Medpace operates as a leading clinical contract research organization, providing comprehensive clinical trial management services that enable pharmaceutical and biotech companies to navigate complex development processes. These mid-cap healthcare firms represent a mix of technological advancement, service excellence, and market responsiveness, making them compelling investment options for 2025. Dive into our detailed analysis to see why they could thrive in your portfolio.
Tags: stocks